CD44 and metastatic malignant neoplasm in the lymph nodes: The distribution of co-expression for CD44 and CD133 did not exhibit significant statistical differences across various clinicopathological parameters, including age, BMI, pathological type, cervical stromal invasion, lymph node metastasis, and P53 expression.